Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Pere Barba, María Luisa Guerra-Domínguez et al.|Haematologica|2022Cited by 131
Allogeneic Stem Cell Transplantation As Consolidation Therapy in Patients with Relapsed-Refractory B-Cell Lymphoma Exposed to Bispecific Antibodies: A Study on Behalf of Grupo Español De Transplante y Terapia Celular (GETH-TC)Marta Peña, Alberto Mussetti, Giulia Losi et al.|Blood|2024Cited by 2
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC studyMarta Bravo Peña, Alberto Mussetti, Giulia Losi et al.|Blood Advances|2026Cited by 1
Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific AntibodiesGiulia Losi, Alberto Mussetti, Marta Peña et al.|Blood|2024Cited by 0